Avelumab With Chemoradiation for Stage II/III Resectable Esophageal Cancer

Condition:   Resectable Esophageal Cancer
Interventions:   Combination Product: Avelumab combined with Chemoradiation;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Radiation
Sponsors:   University of Wisconsin, Madison;   National Cancer Institute (NCI)
Not yet recruiting

https://ift.tt/2HgsmBw